Olympus has made its fourth Chinese investment with a growth capital infusion in Zhongwang International, the world's third largest aluminium profile company.
1 min read · 12 January 2013
As the New York-based private equity real estate firm prepares its European debt fund, it has added additional capital to its US debt vehicle.
1 min read · 12 January 2013
The $72.3bn US pension joins a raft of North American funds recording losses for the year to June 30. Once again real estate was the best performing asset class returning 8.74%, followed by fixed income and private equity.
2 min read · 12 January 2013
The Texas private equity real estate firm formerly known as N3 Capital Partners has renamed itself after a landmark bridge in Austin, where it is relocating its headquarters. The firm, which closed its debut fund on $250m last year, is targeting commercial and residential real estate as well as land assets.
2 min read · 12 January 2013
Private equity-backed Mrs. Fields Famous Brands plans to file for Chapter 11 as declining consumer spending takes its toll. The shopping mall-centred company's Mrs. Fields and TCBY franchise stores have suffered closures since 2004.
2 min read · 12 January 2013
The head of JC Flowers has reportedly established a fund under his personal control – a possible solution to stringent US bank holding company regulations.
2 min read · 12 January 2013
The president of private equity real estate firm GoldenTree InSite Partners, Tom Shapiro, has warned the US real estate market is in store for more pain ahead as fundamentals, such as rents, weaken. It comes as UK real estate company, British Land, said prospective rents were “drifting downwards.”
2 min read · 12 January 2013
The publicly traded Canadian buyout firm expects to hold a final close on its third mega-fund in early 2009. CEO Gerald Schwartz has said despite having done no deals in the second quarter, Onex sees attractive opportunities and is not discouraged by credit conditions.
2 min read · 12 January 2013
The private equity firms have agreed to sell Talecris Biotherapeutics, purchased for $590m in 2005, to Australian blood products company CSL.
2 min read · 12 January 2013
Private equity now makes up 11 percent of the Canadian pension’s capital under management, which has grown to nearly $128bn. The CPPIB has narrowly bucked the loss-making trend among North American pension funds, recording a 1 percent total return on investments in the three months ended in June.
2 min read · 12 January 2013
